Use of Pembrolizumab in tumor-agnostic MSI-high patients

Richard M. Goldberg, MD, FAnnual Meeting of West Virginia University Cancer Institute discusses the use of pembrolizumab in tumor-agnostic MSI-high patients at the 2017 Annual Meeting Annual Meeting in Chicago, IL.